Emory Report homepage  

November 13 , 2006
Winship Institute appoints Leyland-Jones new director

Brian Leyland-Jones has been appointed associate vice president and director of Emory University’s Winship Cancer Institute.

Leyland-Jones is currently the Minda de Gunzberg Chair in Oncology and professor of medicine at McGill University in Montreal, Canada. From 1990 to 2000, he served as founding chair of oncology and director of the McGill University Comprehensive Cancer Centre.

“We are delighted to announce that Dr. Leyland-Jones will join the Emory Winship Cancer Institute,” said Michael M.E. Johns, executive vice president of health affairs for Emory University. “He comes to Emory with a vision for the future of Winship and experience in making that vision a reality.”

Leyland-Jones holds biochemistry, medical and doctoral degrees from the University of London. He completed a clinical pharmacology fellowship at Cornell University and a medical oncology fellowship at Memorial Sloan-Kettering Cancer Center. He then joined the academic staff at Memorial Sloan-Kettering Cancer Center and New York Hospitals.

In 1983, he moved to the National Cancer Institute to head the Developmental Chemotherapy section.
While at McGill, Leyland-Jones led development of clinical trials that integrated research with five clinical trial cooperative groups and more than 40 pharmaceutical companies.

TOP